Renaissance Technologies’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $95.5M | Sell |
|
|||||
2025
Q1 | $130M | Buy |
|
|||||
2024
Q4 | $123M | Sell |
|
|||||
2024
Q3 | $117M | Buy |
|
|||||
2024
Q2 | $109M | Sell |
|
|||||
2024
Q1 | $140M | Sell |
|
|||||
2023
Q4 | $151M | Sell |
|
|||||
2023
Q3 | $169M | Buy |
|
|||||
2023
Q2 | $160M | Buy |
|
|||||
2023
Q1 | $184M | Sell |
|
|||||
2022
Q4 | $206M | Sell |
|
|||||
2022
Q3 | $173M | Sell |
|
|||||
2022
Q2 | $222M | Sell |
|
|||||
2022
Q1 | $236M | Sell |
|
|||||
2021
Q4 | $217M | Sell |
|
|||||
2021
Q3 | $260M | Sell |
|
|||||
2021
Q2 | $412M | Sell |
|
|||||
2021
Q1 | $438M | Sell |
|
|||||
2020
Q4 | $511M | Sell |
|
|||||
2020
Q3 | $476M | Sell |
|
|||||
2020
Q2 | $384M | Buy |
|
|||||
2020
Q1 | $343M | Sell |
|
|||||
2019
Q4 | $530M | Buy |
|
|||||
2019
Q3 | $400M | Buy |
|
|||||
2019
Q2 | $364M | Buy |
|
|||||
2019
Q1 | $285M | Buy |
|
|||||
2018
Q4 | $143M | Buy |
|
|||||
2018
Q3 | $151M | Buy |
|
|||||
2018
Q2 | $143M | Sell |
|
|||||
2018
Q1 | $145M | Sell |
|
|||||
2017
Q4 | $168M | Buy |
|
|||||
2017
Q3 | $178M | Buy |
|
|||||
2017
Q2 | $187M | Buy |
|
|||||
2017
Q1 | $168M | Sell |
|
|||||
2016
Q4 | $170M | Buy |
|
|||||
2016
Q3 | $111M | Buy |
|
|||||
2016
Q2 | $102M | Buy |
|
|||||
2016
Q1 | $28.1M | Buy |
|
|||||
2015
Q4 | $2.64M | Sell |
|
|||||
2015
Q3 | $16.5M | Buy |
|
|||||
2015
Q2 | $3.22M | Buy |
|
|||||
2014
Q3 | – | Sell |
|
|||||
2014
Q2 | $1.65M | Sell |
|
|||||
2014
Q1 | $7.6M | Buy |
|
|||||
2013
Q3 | – | Sell |
|
|||||
2013
Q2 | $10.1M | Buy |
|